Oct 03,2016 11:13 AM
The pharma company successfully completing USFDA inspection at its API facility in Patalganga Plant, Maharashtra.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||494.85||37.00||118,767.08||1,155.85||0.81||2,750.41||101.68|
|Dr Reddys Laboratories Ltd||3,998.90||22.62||66,460.52||502.80||0.63||2,837.90||914.23|
|Divis Laboratories Ltd||2,421.15||50.59||64,263.31||360.73||0.66||1,390.49||266.77|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
No Company Summary found
Reports by wanbury-ltd
14 Feb 2020
05 Feb 2020
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled ... More
14 Nov 2019
13 Nov 2019
This is with reference to the above mentioned subject, we would like to inform you that the Board of... More